Name: Tirzepatide Research Peptide (10–40mg) | RUO | NovaVitality
SKU: NV-TIRZ-**
Availability: InStock

Tirzepatide – High-Purity Research Peptide

Tirzepatide is a synthetic, dual GIP and GLP-1 receptor agonist peptide, developed to investigate incretin-mediated metabolic signalling. It has become a focal compound in preclinical research due to its potent effects on glucose homeostasis, energy balance, and appetite regulation. This Tirzepatide research peptide is supplied as a lyophilised solid to ensure stability, purity, and reproducibility in laboratory settings.

Supplied in lyophilised (freeze-dried) form to preserve stability.

What is the Tirzepatide Research Peptide?

Tirzepatide (C₂₂₅H₃₄₈N₄₈O₆₈, MW: 4813.45 g/mol) is a 39-amino-acid peptide engineered to co-activate glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors [Finan et al., Lancet Diabetes Endocrinol (2020), DOI:10.1016/S2213-8587(20)30275-4]. Unlike therapeutic formulations, the Tirzepatide research peptide from NovaVitality is provided exclusively for in vitro and preclinical research — not for human or veterinary use.

Scientific Identifiers

Product Name: Tirzepatide Research Peptide
Catalogue Number: NV-TIRZ-10 / NV-TIRZ-20 / NV-TIRZ-30 / NV-TIRZ-40
CAS Number: 2023788-19-2
Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight: 4813.45 g/mol
Form: Lyophilised Solid
Storage: Store at −20°C, protected from light
Unit Size: 10mg, 20mg, 30mg, 40mg

Usage and Reconstitution

The Tirzepatide research peptide is provided freeze-dried for long-term stability. For laboratory protocols, reconstitute using sterile bacteriostatic water (0.9% benzyl alcohol in saline) or dilute acetic acid (0.1%) in saline, depending on solubility requirements.

⚠️ Note: Tirzepatide may require gentle warming (≤37°C) and brief sonication for full dissolution. Avoid vigorous vortexing to prevent aggregation.

Once reconstituted:

– Aliquot to minimise freeze–thaw cycles

– Store short-term at 2–8°C (≤72 hours)

– For long-term storage: −80°C

For guidance, see our Reconstitution Guide.

Recommended products for reconstitution will be automatically added to the cart → Adjust quantities before checkout.

Tirzepatide Research Peptide: Key Investigational Pathways

Tirzepatide is actively studied in metabolic and neuroendocrine models for its unique dual-receptor activity. Key research areas include:

– Metabolic Regulation – Investigated in hepatocyte and adipocyte cultures for effects on insulin sensitivity, lipolysis, and hepatic glucose output.

– Appetite & Energy Balance – Explored in hypothalamic cell models and rodent feeding assays for neuropeptide Y (NPY) and POMC pathway modulation.

– Dual Incretin Signalling – Evaluated for synergistic GIP/GLP-1 receptor crosstalk in pancreatic β-cell and enterocyte models.

– Receptor Trafficking & Bias – Studied using BRET/FRET assays to characterise biased agonism and internalisation kinetics.

All accessories (syringes, vials, filters) are laboratory handling tools only — not medical devices.

Why Order Tirzepatide from NovaVitality?

– 🔬 Batch-certified: Each Tirzepatide research peptide batch is backed up by a CoA

– 🇬🇧 Fast UK dispatch — discreet, tracked, next-day available

– 📚 Research-first: Zero consumer marketing; full technical support

– 🛡️ RUO-compliant: Meets MHRA, FDA 21 CFR 1271, and EU Annex 1 expectations

– 💬 Protocol support: Get help with solubility, dosing, or assay design

Legal and Safety Information

NovaVitality supplies Tirzepatide strictly for laboratory research and educational use only (RUO). This product is not approved by the FDA, EMA, MHRA, or any agency for human or veterinary use. It is not a drug, supplement, or cosmetic.

⚠️ Critical:

– Do not administer to humans or animals

– Use only under institutional biosafety approval

– Researchers are responsible for ethical oversight (IACUC/IRB where applicable)

NovaVitality disclaims all liability for misuse.